课题基金 / 基金详情

Molecular mechanisms of urotensin II function

Molecular mechanisms of urotensin II function
尾加压素 II 功能的分子机制
批准号:
181473
负责人:
Leduc Richard
金额:
$55.42万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2009
资助国家:
加拿大
项目状态:
已结题
起止时间:
2009-03-01 至 2014-03-01

项目摘要

项目成果

Leduc Richard的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The cardiovascular system is affected by a variety of stimuli, many of which are peptidic in nature. In order to become active most peptidergic hormone precursors are submitted to cleavage by proteases. This permits the production of the bioactive peptide
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
COVID-19 Variant Supplement - Preventing SARS-CoV-2 infection by targeting human type II transmembrane serine protease activity
  • 批准号:
    443033
  • 项目类别:
    Operating Grants
  • 资助金额:
    $3.64万
  • 财政年份:
    2021
  • 负责人:
    Leduc Richard
  • 依托单位:
Sex as a Biological Variable Supplement - Preventing SARS-CoV-2 infection by targeting human type II transmembrane serine protease activity
  • 批准号:
    424692
  • 项目类别:
    Operating Grants
  • 资助金额:
    $3.64万
  • 财政年份:
    2020
  • 负责人:
    Leduc Richard
  • 依托单位:
Targeting TMPRSS6 to treat hepcidin-deficiency disorders.
  • 批准号:
    435028
  • 项目类别:
    Operating Grants
  • 资助金额:
    $69.94万
  • 财政年份:
    2020
  • 负责人:
    Leduc Richard
  • 依托单位:
Preventing SARS-CoV-2 infection by targeting human type II transmembrane serine protease activity
  • 批准号:
    422696
  • 项目类别:
    Operating Grants
  • 资助金额:
    $62.36万
  • 财政年份:
    2020
  • 负责人:
    Leduc Richard
  • 依托单位:
海外基金